RxDoctor Payments Data

Sarah Ball

Nurse Practitioner · Millersport, OHNPI 1447807904

Payments from drug & device makers

$2,001in general payments, 2019–2025

Across 119 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$481
  • AbbVie$319
  • Exact Sciences$198
  • Corcept Therapeutics$143
  • Phathom Pharmaceuticals, Inc.$104
  • Bayer$91
  • plus $665 from 12 others

What the payments were for

  • Food & beverage$2,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,001 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$49,245
Medicare patients
124
Services billed
691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin36$36,405
OzempicSemaglutide27$33,534
EliquisApixaban21$18,866
Tresiba Flextouch U-200Insulin Degludec18$11,154
Potassium Chloride69$4,399
Advair HfaFluticasone Propion/Salmeterol13$3,993
Venlafaxine Hcl ErVenlafaxine Hcl37$2,308
Atorvastatin Calcium192$1,592
Valsartan22$1,499
Omeprazole141$1,467
Albuterol Sulfate HfaAlbuterol Sulfate47$1,321
Rosuvastatin Calcium73$1,316
Duloxetine Hcl17$1,145
Levothyroxine Sodium160$1,097
Tamsulosin Hcl34$948

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$36,40536 claims
Novo NordiskOzempic$481$33,53427 claims
PfizerEliquis$82$18,86621 claims
AbbVieSynthroid$319$31321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Millersport

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →